Can-Fite Biopharma Ltd Sponsored ADR (Israel) Analysis
| Analyst Ratings |
|
Average Target Price
|
6.63
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.19
|
0.00
|
0.19
|
100.00%
|
|
2022-12-31
|
-0.09
|
0.00
|
0.09
|
100.00%
|
|
2022-09-30
|
-0.11
|
-0.09
|
0.02
|
18.18%
|
|
2022-06-30
|
-0.10
|
-0.08
|
0.02
|
20.00%
|
|
2022-03-31
|
-0.14
|
-0.09
|
0.05
|
35.71%
|
|
2021-12-31
|
-0.18
|
-0.30
|
-0.12
|
-66.67%
|
|
2021-09-30
|
-0.09
|
-0.19
|
-0.10
|
-111.11%
|
|
2021-06-30
|
-0.10
|
-0.19
|
-0.09
|
-90.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.26
|
|
2021-12-31
|
-0.80
|
|
2020-12-31
|
-1.74
|
|
2019-12-31
|
-9.77
|
|
2018-12-31
|
-4.56
|
|
2017-12-31
|
-4.72
|
|
2016-12-31
|
-1.06
|
|
2015-12-31
|
0.08
|
|
2014-12-31
|
-3.78
|
|
2013-12-31
|
-11.11
|
|
2012-12-31
|
-4.65
|